B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.
Vooijs, W. C., Otten, H. G., Van Vliet, M., Van Dijk, A. J., De Weger, R. A., De Boer, M., ...
In this preclinical study, the potential applicability of an anti-B7-1 immunotoxin (IT) for the treatment of Hodgkin's disease (HD) was investigated. Immunohistochemical analysis demonstrated strong...